BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3057238)

  • 1. Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability.
    Treiger B; Isaacs J
    J Urol; 1988 Dec; 140(6):1580-6. PubMed ID: 3057238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection.
    Ichikawa T; Schalken JA; Ichikawa Y; Steinberg GD; Isaacs JT
    Prostate; 1991; 18(2):163-72. PubMed ID: 2006121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic instability and the acquisition of metastatic ability by rat mammary cancer cells following v-H-ras oncogene transfection.
    Ichikawa T; Kyprianou N; Isaacs JT
    Cancer Res; 1990 Oct; 50(19):6349-57. PubMed ID: 2119253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene.
    Partin AW; Isaacs JT; Treiger B; Coffey DS
    Cancer Res; 1988 Nov; 48(21):6050-3. PubMed ID: 3048653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
    Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
    Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system.
    Cooke DB; Quarmby VE; Petrusz P; Mickey DD; Der CJ; Isaacs JT; French FS
    Prostate; 1988; 13(4):273-87. PubMed ID: 3064050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1.
    Davies BR; Davies MP; Gibbs FE; Barraclough R; Rudland PS
    Oncogene; 1993 Apr; 8(4):999-1008. PubMed ID: 8455951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial growth suppression of human prostate cancer cells by the Krev-1 suppressor gene.
    Burney TL; Rockove S; Eiseman JL; Jacobs SC; Kyprianou N
    Prostate; 1994 Oct; 25(4):177-88. PubMed ID: 8084835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells.
    Ke Y; Beesley C; Smith P; Barraclough R; Rudland P; Foster CS
    Br J Cancer; 1998; 77(2):287-96. PubMed ID: 9461000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
    Ichikawa T; Ichikawa Y; Isaacs JT
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
    Waghorne C; Kerbel RS; Breitman ML
    Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic factors and metastatic potential of prostatic cancer.
    Ichikawa T; Ichikawa Y; Isaacs JT
    Cancer Surv; 1991; 11():35-42. PubMed ID: 1841756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells.
    Collard JG; Schijven JF; Roos E
    Cancer Res; 1987 Feb; 47(3):754-9. PubMed ID: 3802080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
    Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines.
    Davies BR; Barraclough R; Rudland PS
    Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of colony forming ability in the lung by transfer of the v-fos oncogene into a ras-transformed rat 3Y1 cell line.
    Nakamatsu K; Taniguchi S; Kimura G; Baba T
    FEBS Lett; 1989 Nov; 257(2):422-6. PubMed ID: 2511041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oncogene transfection or passage in vivo on malignant phenotypes of rat2 cells.
    Van Roy FM; Coopman P; Suffys P; Liebaut G; Vleminckx K; Gao J; Dragonetti CH; Fiers W; Mareel MM
    Anticancer Res; 1989; 9(6):1553-64. PubMed ID: 2697182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIH3T3 transfectant containing human K-ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co-culture with fibroblasts.
    Takiguchi Y; Takahashi Y; Kuriyama T; Miyamoto T
    Clin Exp Metastasis; 1992 Sep; 10(5):351-60. PubMed ID: 1505125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.